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Keratinocyte Apoptosis in Epidermal Remodeling and
Clearance of Psoriasis Induced by UV Radiation
Sophie C. Weatherhead1,2, Peter M. Farr2, David Jamieson3, Jennifer S. Hallinan4, James J. Lloyd5,
Anil Wipat4 and Nick J. Reynolds1,2
Psoriasis is a common chronic skin disorder, but the mechanisms involved in the resolution and clearance of
plaques remain poorly defined. We investigated the mechanism of action of UVB, which is highly effective in
clearing psoriasis and inducing remission, and tested the hypothesis that apoptosis is a key mechanism. To
distinguish bystander effects, equal erythemal doses of two UVB wavelengths were compared following in vivo
irradiation of psoriatic plaques; one is clinically effective (311 nm) and one has no therapeutic effect on psoriasis
(290 nm). Only 311 nm UVB induced significant apoptosis in lesional epidermis, and most apoptotic cells were
keratinocytes. To determine clinical relevance, we created a computational model of psoriatic epidermis.
Modeling predicted apoptosis would occur in both stem and transit-amplifying cells to account for plaque
clearance; this was confirmed and quantified experimentally. The median rate of keratinocyte apoptosis from
onset to cell death was 20minutes. These data were fed back into the model and demonstrated that the
observed level of keratinocyte apoptosis was sufficient to explain UVB-induced plaque resolution. Our human
studies combined with a systems biology approach demonstrate that keratinocyte apoptosis is a key mechanism
in psoriatic plaques clearance, providing the basis for future molecular investigation and therapeutic
development.
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INTRODUCTION
Psoriasis is a chronic disabling skin disorder affecting 25
million people in North America and Europe (Lowes et al.,
2007), and has been estimated to cost the US $1,500 per
patient per year (Fowler et al., 2008). The pathogenesis of
psoriasis is complex with interplay between genetic predis-
position, external environmental triggers, and innate and
adaptive immune responses. Recent genetic and functional
studies have highlighted the role of innate immunity and
cytokine signals, specifically IL-17/IL-22, which appear
critical in initiating epidermal remodeling and the formation
of psoriatic plaques (Di Cesare et al., 2009; Elder, 2009).
Interestingly, genetic and gene array data underscore a
fundamental role for the epidermis in psoriasis pathogenesis
(de Cid et al., 2009; Wolf et al., 2010). Moreover, psoriatic
keratinocytes differ from normal keratinocytes as evidenced
by increased proliferative potential (Weinstein et al., 1984),
dysregulated intracellular signaling pathways, including
calcium signaling (Karvonen et al., 2000) and activated
STAT3 (Sano et al., 2005). Transgenic mice with constitu-
tively active STAT3 develop a psoriatic phenotype, but
require activated T-cells to be present for this to occur (Sano
et al., 2005). These studies indicate that the development of
psoriasis is dependent on complex interactions between the
innate immune system, dendritic cells, and activated T-cells
driving genetically predisposed abnormal keratinocytes.
Despite advances in understanding pathogenesis, less
attention has been paid to investigating the mechanisms
involved in resolution of psoriatic plaques, which are up to
four times thicker than normal uninvolved skin, back to
normal architecture in response to therapy. Several different
mechanisms have been proposed (Ozawa et al., 1999;
Sauder, 2004; McGill et al., 2005; Johnson-Huang et al.,
2010), but the evidence is based principally on temporal
association of particular observations with stages of plaque
resolution or from xenograft mouse models. UVB
(280–315 nm) phototherapy remains one of the mainstays of
treatment (Menter et al., 2010) and can induce clearance of
psoriasis in around 70% of patients (Coven et al., 1997;
Gordon et al., 1999; Kirke et al., 2007), often with prolonged
remission (Dawe et al., 1998). UVB exerts a multitude of
biological effects within skin, but it remains unclear which of
these induce clearance of psoriasis.
In this work, we have used an approach, which to our
knowledge has not previously been reported, studying the
response to equal erythemal doses of a clinically effective
wavelength (311 nm) and a proven ineffective wavelength
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(290 nm; Parrish and Jaenicke, 1981). This allowed us to
distinguish potentially important therapeutic actions of UVB
from bystander effects. The erythema action spectrum of UVB
is similar to the action spectrum of DNA damage (Setlow,
1974) and non-melanoma skin cancer induction (Setlow,
1974; de Gruijl and Van der Leun, 1994), but is distinct from
the therapeutic action spectrum of UVB in the clearance of
psoriasis (Parrish and Jaenicke, 1981). Moreover, we have
developed a model of epidermal homeostasis, which has
allowed us to create an in silico model of psoriasis. This was
then used to identify key in vivo and in vitro experiments, the
results of which were then fed back into the model. Uniquely,
the model represents the dynamic development of psoriatic
plaques and the response to therapeutic intervention in a
stochastic manner. We demonstrate that the observed rate of
keratinocyte apoptosis is sufficient to allow psoriatic epider-
mis to remodel back to normal, and this can account for
plaque clearance.
RESULTS
Wavelength dependence of apoptosis in psoriatic epidermis
Although psoriatic keratinocytes appear resistant to apoptosis in
cell culture (Wrone-Smith et al., 1997), we hypothesized that
apoptosis may be involved in the clearance of plaques in
response to therapeutic UV irradiation. To test this, we exposed
psoriatic plaques to single two to three minimal erythemal doses
(MEDs) of 311 and 290nm UV, and counted cells immuno-
stained with anti-active caspase-3 (indicating apoptosis). The
background number of apoptotic cells in un-irradiated lesional
psoriatic skin (n¼29) was found to be very low (median 0.1 cells
per 1,000 nucleated epidermal cells), consistent with previous
literature (Laporte et al., 2000). In contrast, Figure 1a shows a
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Figure 1. Significant apoptosis following in vivo irradiation of psoriatic plaques with 311 nm UVB. (a) Representative confocal image of lesional psoriatic
epidermis at 18 hours post in vivo irradiation, immunostained with anti-active caspase-3 (green) and Toto-3 (blue). Dotted line shows the basement membrane.
Bar¼100 mm. (b) Number of anti-active caspase-3 (apoptotic) cells within lesional psoriatic epidermis seen at 16–48 hours following irradiation with
either 311 or 290 nm compared with un-irradiated psoriasis. Lines show medians (12/1,000 and 0/1,000 epidermal cells for 311 and 290, respectively)
and inter-quartile range. (c) Time-course showing number of apoptotic cells in lesional psoriatic epidermis post UV. Crosses show median number of
apoptotic cells per 1,000 epidermal nucleated cells, and inter-quartile range. Red bars represent irradiation with 311 nm, blue represents 290 nm (note median
and inter-quartile range is 0 at time-points 0–8, 8–16, and 24–32 hours), and black bar is un-irradiated psoriatic epidermis. (d) Mean (±standard error) number of
apoptotic cells in lesional psoriatic epidermis in 10 patients at 24 hours post 311 nm UVB irradiation. Increasing apoptotic response is seen with increasing doses
of UVB (means of 1.3, 2.1, 9.1, and 14.3 per 1,000 epidermal cells, respectively), which is significantly different from un-irradiated psoriasis at all doses.
(e) Apoptotic response in five patients at 24hours after a single 311nm exposure to psoriasis in vivo and at 24hours after the 4th, 8th, and 12th dose during a
routine treatment course. One patient dropped out during treatment because of burning. *Po0.05, **Po0.01. Note the log scale used in figures a, c, and d.
MEDs, minimal erythemal doses.
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significant increase in apoptosis of lesional epidermal cells
between 16 and 48hours following irradiation with 311nmUVB
but not with equally erythemogenic doses of 290nm (Po0.001).
Inter-patient variation in the number of apoptotic cells resulting
from a single three MED dose of 311nm was seen, but
measurement error testing showed that this was significantly
greater than intra-patient variation (Supplementary Figure S1
online). A within-patient study (n¼9) showed inter-patient
variation in the time-course of apoptosis (Supplementary Figure
S2 online), but overall the number of apoptotic cells induced by
311nm peaked at 16–24hours (Figure 1c), and were located in
the basal or suprabasal epidermis, consistent with an effect on
the proliferative compartment (Figure 1a, Supplementary Figure
S3 online). To exclude the possibility that 290nm induced a
different apoptotic time-course, biopsies were examined be-
tween 2 and 48hours, and at no time points were significantly
increased numbers of apoptotic cells seen following 290nm
irradiation (Figure 1c).
To test whether the apoptotic response following erythe-
mogenic doses of 311 nm are representative of those
following routine clinical doses, we measured apoptosis at
24 hours after irradiation of matched psoriatic plaques with
single doses of 0.75, 1, 2, and 3 MEDs (Figure 1d). As
expected, 2 and 3 MEDs induced a significantly higher rate of
apoptosis than 0.75 and 1 MEDs (Po0.001). Importantly,
apoptosis induced by 0.75 and 1 MED of 311 nm was
significantly greater than un-irradiated psoriasis (Po0.001).
Routine UVB treatment of psoriasis uses repeated sub-
erythemogenic doses three times per week for 6–8 weeks. To
confirm that epidermal apoptosis occurred during clinical
therapy, apoptotic cells were counted in biopsies taken from
psoriatic plaques 24 hours following the 4th, 8th, and 12th
routine treatment (n¼ 5). Apoptosis was significantly greater
(mean of 2.5 cells per 1,000 epidermal cells) compared with
un-irradiated psoriasis (P¼ 0.001; n¼29; Figure 1e). Linear
regression analysis showed no significant correlation be-
tween the number of 311 nm-induced apoptotic cells within
the epidermis and maximal plaque thickness (P¼0.079,
r2¼ 0.06, n¼ 43).
Apoptotic cells are predominantly keratinocytes
The location, morphology, and double immunostaining of
apoptotic cells with specific keratinocyte markers suggested
that these cells were predominantly keratinocytes (Figure 2a).
However, it has previously been proposed that T-cells within
lesional psoriatic skin are differentially susceptible to UVB-
induced apoptosis, resulting in a reduction in T-cell-derived
cytokines that drive keratinocyte proliferation and thereby
leading to plaque resolution (Krueger et al., 1995). To
investigate apoptosis in different cell types, epidermal
sections were triple labelled with anti-active caspase-3,
Toto-3, and specific markers of cell origin, and colocalization
coefficients were determined (Figure 2b and d). These data
showed that 95% of apoptotic cells within psoriatic
epidermis were keratinocytes and 0.4% were T-cells,
reflecting the relative proportion of these cells identified
within the epidermis. This suggests that keratinocytes and
T-cells show a similar susceptibility to UV-induced apoptosis.
To rule out the possibility that the time-course of apoptosis
differed in T-cells, paired biopsies taken from 4–48 hours
were studied, and no significant change in the number of
these cells within plaques irradiated with 311 or 290 nm were
seen at any time point (P¼ 0.11). Apoptotic cells were rarely
seen within the dermis.
To confirm UV-induced apoptosis within psoriatic plaques
and to confirm that apoptotic cells were predominantly
keratinocytes, transmission electron microscopy was per-
formed at 24 hours post irradiation with three MEDs of 311
and 290nm (n¼ 3). Morphological changes of keratinocyte
apoptosis were observed following irradiation with 311 nm
only, as evidenced by cell shrinkage and condensation of
chromatin. These cells were identified as keratinocytes by the
presence of both keratin filaments and desmosomal junctions
(Figure 2c).
Wavelength dependence of apoptosis is not seen in vitro
The effect of equal erythemally weighted doses (2–10
standard erythemal doses; SEDs) of 290 and 311 nm UVB
were compared in primary cultured keratinocytes (Figure 3).
Notably, there was no significant difference in the cumulative
proportions of apoptotic cells following 290 and 311nm
irradiation with the real-time, live cell caspase-3 substrate
assay (Cen et al., 2008; P40.05; Figure 3a), and these had a
similar time-course of apoptosis, peaking between 16 and
24 hours post irradiation. For 311 nm, doses of six to eight
SEDs resulted in the highest levels of apoptosis (Figure 3b)
and increasing doses of 311 nm resulted in earlier onset of
apoptosis (Figure 3c). Similar results were obtained by flow
cytometry at a single time point (24 hours) with 290 nm
inducing greater apoptosis than equal erythemally weighted
doses of 311 nm (Figure 3d), although this difference was not
significant (P¼ 0.165, n¼3), but was significantly greater
than sham irradiation (P¼ 0.014).
Lack of differential effects of 311 and 290 nm on keratinocyte
proliferation within plaques
To investigate the potential contribution of reduced epider-
mal proliferation induced by UVB on plaque clearance, the
numbers of Ki67þ epidermal cells were counted between
4 and 48 hours following irradiation with 290 and 311nm in
matched plaques within the same individuals (n¼ 21). No
significant difference in Ki67þ cells was observed following
irradiation with either 290 nm (P¼0.339) or 311 nm
(P¼0.091) compared with un-irradiated lesional skin (means
of 143, 111, and 162 per 1,000 epidermal cells for un-
irradiated, 290- and 311-nm-irradiated lesional skin, respec-
tively).
A computational model of psoriatic epidermis
As no suitable mathematical model of psoriatic epidermis
exists to date, a stochastic agent-based mathematical model
of the non-lesional and psoriatic keratinocyte compartment of
the epidermis was created, based on histological observations
and previously published experimental data (Figure 4a
and b). The model incorporates a threshold switch in the
proportion of stem and transit-amplifying (TA) cells that
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proliferate, which is consistent with an immunological
stimulus initiating psoriasis through cytokine signals that
induce keratinocyte proliferation. However, once a plaque is
established, it is self-propagating and will remain ‘‘psoriatic’’,
even when initial ‘‘cytokine stimulus’’ is completely with-
drawn. Iterative simulation of the model allowed rigorous
testing and establishment of robust boundaries within which
the model remained stable (Figure 4c). In contrast to adjusting
cell cycle times, the model showed that increasing the
proportion of actively dividing stem and TA cells within
‘‘normal’’ epidermis (Figure 4a–e) were key events contribut-
ing to the development of psoriasis. The model showed
excellent concordance with existing data, including an
absolute increase in both the proliferative and differentiating
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Figure 2. Colocalization of apoptotic cells within lesional psoriatic epidermis with markers specific for epidermal cell types at 24 hours post irradiation with
311 nm UVB. (a, b) Mid Z-section of a confocal image showing colocalization of apoptotic cells (green) with keratinocyte markers (a) and other epidermal
cell types (red; b). Bar¼ 100mm. CD3 is a marker for T-cells, Langerin for Langerhans cells, Melan A for melanocytes, and CD68 for monocyte/macrophages.
Dotted line represents the basement membrane. (c) Transmission electron micrograph showing an apoptotic keratinocyte. Insert shows keratin filaments.
Desmosomal junctions between the cells were also seen, confirming cells are keratinocytes. Bar¼2 mm. (d) Table summarizing the colocalization coefficients
for apoptotic cells and the specific epidermal cell markers. Note that a small number of cells (3.4%) could not be identified by colocalization.
These cells were at a late stage of apoptosis, when cell surface markers may be lost.
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compartments to levels found in psoriasis, and a reduction
in both total epidermal turnover time and transit time of
differentiating cells. To attain these parameters, the model
predicted that an absolute increase in the number of both
stem and TA cells proliferating was required to simulate
psoriasis.
To model whether UV-induced keratinocyte apoptosis
could directly impact on epidermal resolution, it was
necessary to determine the rate and duration of keratinocyte
apoptosis as well as the differential sensitivity of stem, TA, or
differentiating cells to apoptosis. Detection of apoptosis in
human tissue in vivo is limited by the availability of the tissue
to sampling to determine the time-course of events and the
rapid clearance of apoptotic cells. Methods such as
immunochemistry can only provide a ‘‘snapshot’’ of what is
occurring in the skin at any one time. As real-time imaging of
individual cells within human epidermis is not possible
in vivo, further experiments were designed to address this
question in vitro.
Time of onset and duration of apoptosis
To estimate the functional consequences of UV-induced
apoptosis on psoriatic epidermal homeostasis, we measured
the time to onset and duration of apoptosis in cultured
primary human keratinocytes following UV irradiation, using
a live cell caspase-3 assay and propidium iodide (as a marker
of cell membrane integrity). Following irradiation with six
SEDs of 311 nm, the mean time to caspase-3 activation was
14 hours, and the median duration of apoptosis before the
loss of membrane integrity was 20minutes (inter-quartile
range 0–70minutes; Supplementary Figure S4a online).
Interestingly, neighboring cells did not seem to influence
each other, and the apoptotic rate and onset was distributed
randomly over the imaged areas.
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Figure 3. Apoptosis occurs following irradiation with 311 and 290nm UVB in primary keratinocytes. (a) A membrane-permeable caspase-3 substrate
and live cell imaging was used for detection of onset of apoptosis. A greater proportion of apoptotic cells were seen at 24 hours following irradiation with six
SEDs of 290 nm than six SEDs of 311 nm, but the time-course was similar. (b) The highest cumulative number of apoptotic keratinocytes occurred following
irradiation with six to eight SEDs of 311 nm UVB. The caspase-3-specific inhibitor successfully blocked caspase-3 activity. Median and inter-quartile ranges
are shown for three separate experiments. A significant difference in the cumulative proportion of apoptosis was seen between indicated doses and sham-
irradiated cells (%) or irradiated cells incubated with caspase-3 and inhibitor (E; Po0.05). (c) Time-course of apoptosis following irradiation with increasing
doses of 311 nm. Higher doses (six to eight SEDs) were associated with a quicker rate of onset of apoptosis. (d) Flow cytometry showing the effects of
irradiation with UVB at a single time point (24 hours). A greater proportion of apoptotic (DEVD-NucView488 caspase-3þ ) and dead (PIþ ) cells are observed
with 290 nm than 311nm. PI, propidium iodide; SED, standard erythemal dose.
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These data were fed back into the model, which predicted
that if psoriasis is expected to clear in 75–90% of patients
after 6–10 treatment sessions using three MED doses (as seen
in the clinical setting following localized irradiation; Feldman
et al., 2002; Trehan and Taylor, 2002), then UV must result in
apoptosis of B15–25% of both stem and TA cells following
each irradiation. To test this prediction, intact normal human
epidermis was irradiated ex vivo, and the proportion of
apoptotic TA cells (a6-integrinþ /CD71þ ) and putative stem
cells (a6-integrinþ /CD71) was determined (Tani et al.,
2000; Youn et al., 2004). Expression of these cell surface
markers changes progressively as the proliferative status of
the cell decreases (Webb et al., 2004). Although the majority
of apoptotic cells expressed high levels of CD71 and a6-
integrin consistent with TA cells (87–89%; median 88%),
CD71/a6-integrinþ (putative stem cells) accounted for
3.4–10% (median 8%). To ensure that each population of
cells was examined in isolation, three gates were examined
from the entire cell population (Supplementary Figure S4b
online). UVB was found to cause a mean relative increase in
apoptotic cells of 20% in TA cells and 13% in stem cells
(Supplementary Figure S4c online). However, as remission
can be maintained following phototherapy, apoptosis alone
cannot account for TA cells switching to fewer rounds of
divisions. The increase in the number of epidermal keratino-
cytes and T-cells within psoriatic plaques will amplify the
local levels of proliferation-inducing cytokines (e.g., IL-20/IL-
22) and growth factors (e.g., transforming growth factor a and
other members of the epidermal growth factor and hepato-
cyte growth factor families) by paracrine/autocrine secretion,
and thereby contribute to the proliferative potential
of epidermal cells (Sano et al., 2005; Wolk et al., 2009).
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Figure 4. Development of a mathematical model of normal and psoriatic epidermis based on histological features, differentiation patterns, and epidermal
kinetics. (a and bi) Model of normal (a) and psoriatic (b) epidermis with stem cells (white, see insert), actively dividing TA cells (pink), resting TA cells (dark pink),
and differentiating cells (green). (a and bii) Two inverted gradients were applied within the model arising from the basement membrane; one maps to the pattern
of keratin-10 immunostaining (green) with a specified threshold determining the onset of keratinocyte terminal differentiation; a second gradient contains
actively dividing TA cells and stem cells (red), and regulates expansion/contraction of the basement membrane. (c) How adjusting relative proportions of actively
dividing stem cells (ci), and TA (cii), or stem cell cycle times (ciii) independently affects turnover time of the whole epidermis. Median and inter-quartile ranges
shown; n¼ 50. (d) Model of ‘‘normal epidermis’’ when the number of TA divisions increases from four to five. Note almost all TA cells in the 4th rete ridge are
proliferating, but very few in the first, resulting in a patchy distribution of proliferation histologically, not consistent with clinical observation. (e) The turnover
times for normal (median 706 hours) and psoriatic (median 270 hours) epidermis used in further experiments. Transit time of differentiated cells (not shown here)
reduced from 336hours to 100 hours.
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This was represented in the model, by gradually reducing the
number of time TA cells divide from five back to four, as the
total number of epidermal cells returned to normal.
Apoptosis in epidermal resolution and plaque clearance
The model showed that repeated doses of three MEDs to
lesional (plaque) psoriasis in silico returned the epidermis to
normal thickness and morphology following approximately
six to eight treatments, and that several treatments were
required before any reduction in epidermal thickness was
seen (Figure 5a–g). The epidermal turnover time increased
following each irradiation, in keeping with the clinical
scenario, whereby characteristics of lesional skin return to
normal (Figure 5h). Following completion of treatment,
remission was maintained (Figure 5g and i). A movie of the
model depicting the development and resolution of psoriatic
epidermis is available at http://research.ncl.ac.uk/psoroasis/,
and is explained in the Supplementary data online. Clearance
of psoriatic plaques occurred irrespective of whether or not
differentiating cells underwent apoptosis, but apoptosis of
both stem and TA cells was necessary to induce timely
clearance and remission (Supplementary Figure S5 online).
Moreover, sub-erythemogenic irradiation takes B25–30
treatments to ‘‘clear’’ psoriasis in the model, consistent with
clinical practice (Dawe et al., 1998; Kirke et al., 2007).
Together these data suggest that keratinocyte apoptosis may
be sufficient to account for plaque clearance in response to
UV irradiation.
To examine whether cell cycle arrest would also lead to
plaque clearance, we substituted cell cycle arrest for apoptosis
within the model. Assuming that arrested cells did not re-enter
the cell cycle, UV-induced cell cycle arrest eventually led to
plaque clearance and remission. In contrast to the apoptotic
model, however, there was a substantial lag phase before a
reduction in plaque thickness was seen, and it took approxi-
mately a further 7–14 days following completion of treatment
for plaques to resolve (Figure 5i). This scenario would not fit
with the clinical situation, as progressive plaque resolution
occurs during a course of UVB treatment without further
significant improvement thereafter.
DISCUSSION
UVB wavelengths of 300–313 nm are highly effective at
clearing psoriasis (Parrish and Jaenicke, 1981), and photo-
therapy is one of the very few treatments that can induce
complete remission of psoriasis for a period of time after
therapy has been withdrawn (Dawe et al., 1998). We have
shown that psoriatic keratinocytes within lesional skin
undergo apoptosis in response to 311 nm irradiation, but
not in response to clinically ineffective 290 nm irradiation.
Further, using in silico modeling, we demonstrate that the
rate of apoptosis induced appears sufficient to account for
plaque resolution during a routine therapy course. These data
identify keratinocyte apoptosis as a key mechanism in
psoriatic plaque clearance in response to UVB. Moreover,
by developing a mathematical model of psoriasis develop-
ment and resolution in response to UVB, we demonstrate the
utility of an integrated systems biology approach to human
disease in situations in which in vivo experiments are limited
by technical and ethical considerations.
As psoriatic plaques tolerate erythemogenic doses of UVB
(Asawanonda et al., 2000), we initially used two to three
MED doses to unequivocally demonstrate epidermal kerati-
nocyte apoptosis, the time-course of apoptosis and a
differential response to a clinically effective wavelength
(311 nm) compared with a clinically ineffective wavelength
(290 nm). Although we have used UVB doses of three MEDs
in several elements of this study, the results can be
extrapolated to the clinical situation for several reasons: first,
as psoriasis is relatively resistant to burning, doses of up to
three to six MEDs of 308 nm from excimer laser (which has
been shown to be of similar efficacy to the 308 nm lamp and
311nm lamp; Kollner et al., 2005; Goldinger et al., 2006) are
used in clinical practice when targeting individual plaques
(Menter et al., 2010). Second, multiple MEDs of UVB result in
more rapid clearing of psoriasis (Asawanonda et al., 2000;
Kollner et al., 2005). Third, we have shown that psoriatic
keratinocytes undergo apoptosis in response to sub-erythe-
mogenic (whole-body clinical) doses of 311 nm UVB (0.75
MEDs), and that apoptosis is also seen during routine courses
of repeated low-dose treatments. However, three MEDs is a
higher dose than would be used for whole-body psoriatic
treatment, as it would cause burning of non-lesional skin and
unacceptable discomfort.
In normal forearm skin, 290nm has been shown to
penetrate into the lower epidermis B14 times less than
314nm (Meinhardt et al., 2009). It is possible, therefore, that
differential penetration of 290 and 311nm UVB contributes, at
least in part, to the differences in number of apoptotic cells
observed with these wavelengths in psoriatic epidermis but not
in vitro. However, we did not find a correlation between
maximal epidermal thickness and the number of apoptotic cells
in 311-nm-irradiated psoriatic plaques. UVB (290nm) clearly
penetrates sufficiently to induce DNA damage and non-
melanoma skin cancer. Indeed, evidence suggests that
293nm is a more potent inducer of non-melanoma skin cancer
in humans than longer UVB wavelengths (de Gruijl and Van
der Leun, 1994), suggesting that differential penetration may
not be the only explanation for our findings.
Phagocytosis is known to begin before membrane disrup-
tion (Dini and Abbro, 2005), although the rate of phagocytosis
of apoptotic cells in vivo remains unknown. Our in vitro
experiments show that the median time of caspase-3 positivity
in individual cells is 20minutes. The rate of apoptosis seen
would be sufficient to allow for clearance of psoriasis in the
model if the apoptotic and subsequent phagocytic process
took approximately at 6 hours or less to complete. This fits with
our data for two reasons: first, we showed significant reduction
in the number of apoptotic cells within the epidermis of
individual subjects when biopsies were taken just at 6 hours
apart (Supplementary Figure S2 online), and second, the
apoptotic cells did not appear to migrate into the upper
epidermis over the time-course (Supplementary Figure S3
online), in contrast to time-course studies in normal human
skin (Qin et al., 2002), suggesting apoptotic cells were
rapidly phagocytosed in psoriatic epidermis.
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Although clearance can be achieved with many psoriatic
therapies, only a few (such as UVB and topical anthralin) can
lead to periods of complete remission (Hartman et al., 2002).
Psoriatic keratinocytes in culture have previously been shown
to be relatively resistant to apoptosis induced by contact
inhibition through culture in methylcellulose (Wrone-Smith
et al., 1997). However, we have previously demonstrated that
anthralin results in apoptosis of cultured keratinocytes
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Figure 5. Mathematical model showing resolution of psoriatic epidermis in response to three MEDs of 311 nm UVB-induced apoptosis. (a–f) Psoriatic
epidermis with elongation of rete ridges and hyperproliferation; different stages of resolution shown until normal state (f) reached; stem cells (white, or gray if
apoptosed, see insert), TA cells (pink), and differentiating cells (green). Non-actively dividing stem cells are shown as dark pink. Basement membrane and below
is shown in yellow. (g) Progressive reduction in cell numbers following sequential UVB irradiation every 56 hours (equivalent to three times per week). In this
experiment, seven doses were required to cause resolution of the psoriasis back to normal. Green arrow shows first irradiation, and red arrow shows final
irradiation. (h) Turnover time increases with each dose of UVB as epidermis returns to normal. Irradiation frequency was reduced to 200 hours for the turnover
time calculation to allow stability of the model for each measurement. (i) Comparison of time taken for cell numbers to return to normal if apoptosis versus cell
cycle arrest is the major mechanism involved in plaque clearance. Note that the time taken for complete resolution following irradiation is significantly
prolonged if the mechanism is cell cycle arrest, with a lag time of 336 hours (14 days) from completion of treatment until resolution is completed, although the
same number of irradiations were required. Furthermore, in this model remission does not begin until after the UV course is completed, which would not fit with
the clinical scenario.
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(McGill et al., 2005). It is possible that treatments capable of
inducing remission act through a different mechanism to
other treatments (e.g., immune-modifying agents), and the
data presented here along with the anthralin studies (McGill
et al., 2005) would support keratinocyte apoptosis as the
mechanism directly responsible for resolution of psoriatic
plaques following treatment with these modalities.
Although psoriasis appears to be triggered by immuno-
cyte-derived cytokines, the model suggests that plaques can
be maintained by an increased proportion of actively dividing
stem and TA cells. Interestingly, altering cell cycle times
alone did not result in a psoriatic phenotype with a turnover
time in keeping with known kinetic parameters. The model
predicted that apoptosis of both stem and TA cells would be
required to remodel psoriatic plaques back to ‘‘normal’’, and
this was validated experimentally. Apoptosis of differentiating
cells did not affect the outcome of the model over time.
Creating the model highlighted a number of important
questions that were necessary to tackle experimentally.
Apoptosis is a dynamic process but is often measured with
end-point assays, such as immunohistochemistry. Without
understanding the rate of apoptosis, it is impossible to predict
the overall impact of this on overall tissue homeostasis,
and this question was therefore addressed with live-cell
assays.
Overall this study clearly demonstrates that significant
apoptosis occurs in psoriatic keratinocytes following irradia-
tion with therapeutic wavelengths of UVB in vivo, and
establishes a proof of principal that the rate of apoptosis seen
is sufficient to allow resolution of plaques and clearance of
psoriasis during a routine therapeutic course. Individual
variation in response to treatment in the clinical scenario may
depend on factors regulating susceptibility of psoriatic
epidermis to apoptosis, and further studies are required to
address these. Moreover, identification of keratinocyte
apoptosis as a key mechanism involved in psoriatic plaque
clearance provides the basis for future drug development and
optimization of current therapeutic regimes.
MATERIALS AND METHODS
Subjects
In all, 64 adult subjects (41 male and 23 female) with psoriasis were
recruited from a tertiary referral dermatology clinic following the
decision to treat their psoriasis with 311 nm UVB. Exclusion criteria
included the use of sun beds or sun exposure to the lower back for
the preceding 3 months or use of topical anti-psoriatic treatments
(with the exception of emollients) for 2 weeks, and the use of anti-
psoriatic systemic therapies for 3 months. This study was approved
by the Regional Research Ethics Committee, and all subjects gave
written informed consent to participate. The study was conducted
according to the declaration of Helsinki principles.
In vivo UVB
Involved (plaque) or uninvolved psoriatic skin was irradiated in a
maximum of four 15mm diameter areas in the sun-protected region
of the lower back. Psoriatic plaques were chosen to be of similar size
and thickness within each patient, and where possible small plaques
were chosen, which could be biopsied in full. For larger plaques, a
biopsy was taken from the edge of a plaque. Plaques were irradiated
with up to three MED narrowband UVB from a handheld-modified
erythema test unit (Hybec, Leicester, UK, fitted with a Philips TL01
lamp (Philips, Amsterdam, The Netherlands); referred to as 311 nm
in this paper) or an irradiation monochromator set at a central
wavelength of 290 nm (bandwidth 5 nm, measured as full width at
half maximum height).
In vitro UVB
Doses of 0–10 SEDs of 311 and 290nm UVB were used to irradiate
primary cultured keratinocytes. An SED is an erythemal weighted
dose, whereby one SED is equivalent to an erythemal effective
radiant exposure of 100 Jm2 (Diffey et al., 1997). In experiments to
determine median time of apoptosis, cells were irradiated with six
SEDs of 311 nm.
Biopsies
In each patient, 6-mm punch biopsies were taken from psoriatic
plaques or adjacent non-lesional skin before and after irradiation
with 311 or 290 nm UVB. A maximum of four biopsies were taken
per patient. Biopsies were snap frozen, set in optical coherence
tomography (Raymond A Lamb) embedding medium and stored at
80 1C. Details of immunohistochemistry are given in the Supple-
mentary data online.
Electron microscopy
Epidermal sections of 2mm diameter were processed for transmis-
sion electron microscopy, following fixation in 2% gluteraldehyde in
Sorensons’s phosphate buffer, and secondary fixation in 1% osmium
tetraoxide. Samples were then dehydrated in acetone and embedded
in resin before analysis.
In vitro time-course of apoptosis following UVB
Normal human foreskin keratinocytes were grown to 70% con-
fluency and irradiated with six SEDs from 311 nm lamps or 290 nm
UVB from a monochromator. Cells were then imaged during
incubation with NucView 488 caspase-3 substrate (1mM; Biotium,
Hayward, CA) as an indicator of apoptosis and propidium iodide
(1mM; Sigma, Poole, UK) as an indicator of loss of membrane
integrity. Further details are given in the Supplementary data online.
Flow cytometric detection of apoptotic cells
Fresh human foreskins were divided into two sections and half of the
intact epidermis was irradiated in phosphate-buffered saline with six
SEDs 311 nm. Both sections were then incubated in dispase
overnight at 4 1C. After 18 hours the epidermis was peeled off the
dermis and incubated in trypsin for 10minutes, then washed twice.
Keratinocytes were then incubated with PE-CD49f (a6-integrin) and
APC-CD71 (BD Pharmingen, Cambridge, UK) for 45minutes. Cells
were washed and incubated with FITC annexin V for 15minutes
(Molecular Probes, Paisley, UK). A BD LSR11 four color flow
cytometer was used to process the cells, and analysis was carried out
using Venturi One software (Applied Cytometry, Sheffield, UK).
Mathematical modeling
A two-dimensional-agent-based model was developed using
Netlogo 4.0.4 which is a programmable modeling environment
suited for complex systems (http://ccl.northwestern.edu/netlogo/.
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Center for Connected Learning and Computer-Based Modeling,
Northwestern University, Evanston, IL). The keratinocyte compartment
can be subdivided into stem cell, TA cell, and differentiating cell
compartments (Dover and Wright, 1991; Webb et al., 2004), which
show distinct patterns of distribution in normal and psoriatic skin. An
agent-based model was created by combining known kinetic
parameters derived from the literature and observed histological
features characteristic of psoriasis. Further details are given in the
Supplementary data online.
Statistics. The repeatability of apoptotic cell counts was calculated
using measurement error (intra-patient standard deviation), with
concordant repeatability was shown using a log (xþ 1) transforma-
tion of the data to a level of 95% confidence. Paired data was
analyzed with a paired T-test, and non-parametric data analyzed
using Mood’s median. The Mann–Whitney U-test was used to
compare the number of apoptotic cells induced by 311 and 290 nm,
and a one-way analysis of variance was used to compare differences
between groups with more than two factors.
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